Literature DB >> 26035279

A Case Study of the Environmental Experience of a Hospitalized Newborn Infant With Complex Congenital Heart Disease.

Jacki M Daniels1, Tondi M Harrison.   

Abstract

BACKGROUND: Infants with complex congenital heart disease are at high risk for developmental delays. Although the etiology of these delays is multifactorial, the physical environment may be a contributory factor. Extensive studies have been conducted in neonatal intensive care units measuring environmental influences on development, resulting in policy and practice changes. Cardiothoracic intensive care units and cardiac step-down units are new environments in which newborns with heart disease receive care. No environmental studies have been conducted in units caring for newborn infants recovering from cardiac surgery.
OBJECTIVE: The aim of this study is to examine the environmental experience of a newborn infant with heart disease after surgical intervention within the first month of life.
METHODS: Measurements of illumination, sound levels, and sleep were recorded on 1 infant for 2 consecutive postoperative days in the cardiothoracic intensive care unit and 2 consecutive days in the step-down unit.
RESULTS: Although average daily noise exposure remained below recommended guidelines on 3 of 4 days, the infant experienced intermittent periods of excessive noise (≥55 dBA) during 59 of 87 hours and 110 episodes of acute noise events greater than 70 dBA. Average daily light exposure was below the recommended guidelines. However, light levels were more than twice the recommended levels at multiple points daily. For each of the 4 observation days, the infant experienced 66 to 102 awakenings during sleep, and sleep durations were less than 30 minutes 90% of the time.
CONCLUSIONS: This study provides the first report of potential environmental stressors in newborn infants cared for in cardiac specialty units. Excessive levels of light and noise as well as frequent interruptions for medical and nursing care may contribute to disorganized sleep and increased patient distress and may impact subsequent neurodevelopment. Studies are needed to identify potentially adverse aspects of the intensive caregiving environment for newborn infants who have undergone cardiac surgery.

Entities:  

Mesh:

Year:  2016        PMID: 26035279     DOI: 10.1097/JCN.0000000000000273

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  5 in total

1.  Feasibility Case Series of Environment and Sleep in Infants With Congenital Heart Disease.

Authors:  Laura Beth Kalvas; Tondi M Harrison
Journal:  Nurs Res       Date:  2020 Sep/Oct       Impact factor: 2.381

2.  Sleep disruption and delirium in critically ill children: Study protocol feasibility.

Authors:  Laura Beth Kalvas; Tondi M Harrison; Sandra Solove; Mary Beth Happ
Journal:  Res Nurs Health       Date:  2022-08-20       Impact factor: 2.238

3.  Individualized Family-Centered Developmental Care: An Essential Model to Address the Unique Needs of Infants With Congenital Heart Disease.

Authors:  Amy Jo Lisanti; Dorothy Vittner; Barbara Medoff-Cooper; Jennifer Fogel; Gil Wernovsky; Samantha Butler
Journal:  J Cardiovasc Nurs       Date:  2019 Jan/Feb       Impact factor: 2.083

4.  Functional deficit in children with congenital heart disease undergoing surgical correction after intensive care unit discharge.

Authors:  Eloisa da Rosa Schunck; Camila Wohlgemuth Schaan; Gabriela Alves Pereira; Nathália Vieira Rosa; Tatiana Coser Normann; Claudia Pires Ricachinevsky; Caroline Tozzi Reppold; Renata Salatti Ferrari; Janice Luisa Lukrafka
Journal:  Rev Bras Ter Intensiva       Date:  2020-07-13

5.  Skin-to-Skin Care Is a Safe and Effective Comfort Measure for Infants Before and After Neonatal Cardiac Surgery.

Authors:  Amy J Lisanti; Abigail C Demianczyk; Andrew Costarino; Maria G Vogiatzi; Rebecca Hoffman; Ryan Quinn; Jesse L Chittams; Barbara Medoff-Cooper
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.624

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.